Preview Mode Links will not work in preview mode

MDedge Cardiocast

MDedge Cardiocast is the weekly news podcast from Cardiology News hosted by interventional cardiologist Jim Dwyer, MD. Subscribe now.

The information in this podcast is provided for informational and educational purposes only.

Dec 27, 2019

ISCHEMIA trial hailed as practice changing
The largest-ever RCT of initial invasive versus conservative management of stable ischemic heart disease makes waves.

DAPA-HF: Dapagliflozin’s HFrEF efficacy confirmed in nondiabetics
Further analyses from the DAPA-HF trial showed dapagliflozin cut death and heart failure...

Dec 20, 2019

Vascepa approved for cardiovascular risk reduction
The FDA’s decision on cutting events in high-risk patients was based primarily on the REDUCE-IT trial.

ENGAGE AF-TIMI: Insulin linked to greater risk for stroke, CV death, bleeding
Novel oral anticoagulants may be preferred over warfarin in patients with diabetes...

Dec 13, 2019

Women have fewer cardiovascular events after non–ST-segment elevation ACS
But they also remain undertreated with guideline-directed therapies.

*  *  *  

Help us make this podcast better! Please take our short listener survey:

*  *  *  

FDA panel rejects vernakalant...

Dec 6, 2019

Icosapent ethyl cost effective in REDUCE-IT analysis
Treatment with the fish-derived drug Vascepa for CV event reduction is more effective and less costly than placebo.

*  *  *  

Help us make this podcast better! Please take our short listener survey:

*  *  *  

Nov 29, 2019

This week’s Cardiocast is devoted entirely to Card Talk with cardiologist brothers Jim and Jerry Dwyer. They welcome two structural interventionalists at the Structural Heart and Valve Center at Emory Healthcare, Kendra J. Grubb, MD, and Isida Byku, MD. Both followed a unique track, training in both cardiac surgery...